Rosetta Genomics (ROSGQ) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartShort Interest Rosetta Genomics Short Interest DataRosetta Genomics (ROSGQ) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 120 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Today's Trading Volume0 sharesAverage Trading Volume120 sharesToday's Volume Vs. Average0% Short Selling Rosetta Genomics? Sign up to receive the latest short interest report for Rosetta Genomics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartROSGQ Short Interest Over TimeROSGQ Days to Cover Over TimeROSGQ Percentage of Float Shorted Over Time Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Rosetta Genomics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024100 shares $0.00 No ChangeN/A0 $0.00 9/30/2024100 shares $0.00 No ChangeN/A1 $0.00 9/15/2024100 shares $0.00 No ChangeN/A0 $0.00 8/31/2024100 shares $0.00 No ChangeN/A1 $0.00 8/15/2024100 shares $0.00 No ChangeN/A0 $0.00 7/31/2024100 shares $0.00 No ChangeN/A0 $0.00 Get the Latest News and Ratings for ROSGQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rosetta Genomics and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024100 shares $0.00 No ChangeN/A0 $0.00 6/30/2024100 shares $0.00 No ChangeN/A0 $0.00 6/15/2024100 shares $0.00 No ChangeN/A0 $0.00 5/31/2024100 shares $0.00 No ChangeN/A0 $0.00 5/15/2024100 shares $0.00 No ChangeN/A0 $0.00 4/30/2024100 shares $0.00 No ChangeN/A0 $0.00 4/15/2024100 shares $0.00 No ChangeN/A0 $0.00 3/31/2024100 shares $0.00 No ChangeN/A0 $0.00 3/15/2024100 shares $0.00 No ChangeN/A1 $0.00 2/29/2024100 shares $0.00 No ChangeN/A0 $0.00 2/15/2024100 shares $0.00 No ChangeN/A0.1 $0.00 1/15/2024100 shares $0.00 No ChangeN/A0 $0.00 12/31/2023100 shares $0.00 No ChangeN/A0 $0.00 12/15/2023100 shares $0.00 No ChangeN/A1 $0.00 11/30/2023100 shares $0.00 No ChangeN/A0 $0.00 11/15/2023100 shares $0.00 No ChangeN/A0.3 $0.00 10/31/2023100 shares $0.00 No ChangeN/A0.3 $0.00 10/15/2023100 shares $0.00 No ChangeN/A1 $0.00 9/30/2023100 shares $0.00 No ChangeN/A1 $0.00 9/15/2023100 shares $0.01 No ChangeN/A0 $0.00 8/31/2023100 shares $0.00 No ChangeN/A0.2 $0.00 8/15/2023100 shares $0.00 No ChangeN/A1 $0.00 7/31/2023100 shares $0.01 No ChangeN/A0.1 $0.00 7/15/2023100 shares $0.00 No ChangeN/A0.1 $0.00 6/30/2023100 shares $0.00 No ChangeN/A1 $0.00 6/15/2023100 shares $0.00 No ChangeN/A1 $0.00 5/31/2023100 shares $0.00 No ChangeN/A0.3 $0.00 5/15/2023100 shares $0.00 No ChangeN/A0.3 $0.00 4/30/2023100 shares $0.00 No ChangeN/A0.1 $0.00 4/15/2023100 shares $0.00 No ChangeN/A1 $0.00 3/31/2023100 shares $0.00 No ChangeN/A0.5 $0.00 3/15/2023100 shares $0.00 No ChangeN/A1 $0.00 2/28/2023100 shares $0.00 No ChangeN/A0.1 $0.00 2/15/2023100 shares $0.00 No ChangeN/A0.2 $0.00This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. 1/31/2023100 shares $0.00 No ChangeN/A1 $0.00 1/15/2023100 shares $0.00 No ChangeN/A0.5 $0.00 12/30/2022100 shares $0.00 No ChangeN/A0.2 $0.00 12/15/2022100 shares $0.01 No ChangeN/A0.1 $0.00 11/30/2022100 shares $0.00 No ChangeN/A0 $0.00 11/15/2022100 shares $0.00 No ChangeN/A0 $0.00 10/31/2022100 shares $0.00 No ChangeN/A0.3 $0.00 10/15/2022100 shares $0.00 No ChangeN/A1 $0.00 9/30/2022100 shares $0.00 No ChangeN/A0 $0.00 9/15/2022100 shares $0.00 No ChangeN/A0.5 $0.00 8/31/2022100 shares $0.00 No ChangeN/A1 $0.00 8/15/2022100 shares $0.02 No ChangeN/A0.3 $0.00 7/31/2022100 shares $0.02 No ChangeN/A1 $0.00 7/15/2022100 shares $0.02 No ChangeN/A1 $0.00 6/30/2022100 shares $0.02 No ChangeN/A1 $0.00 6/15/2022100 shares $0.02 No ChangeN/A1 $0.00 5/31/2022100 shares $0.02 No ChangeN/A0 $0.00 5/15/2022100 shares $0.03 No ChangeN/A0.3 $0.00 4/30/2022100 shares $0.00 No ChangeN/A1 $0.00 4/15/2022100 shares $0.00 No ChangeN/A1 $0.00 3/31/2022100 shares $0.01 No ChangeN/A1 $0.00 3/15/2022100 shares $0.01 No ChangeN/A0 $0.00 2/28/2022100 shares $0.01 No ChangeN/A0 $0.00 2/15/2022100 shares $0.02 No ChangeN/A0.3 $0.00 1/31/2022100 shares $0.10 No ChangeN/A0.3 $0.00 1/15/2022100 shares $0.00 No ChangeN/A0.1 $0.00 12/31/2021100 shares $0.01 No ChangeN/A0 $0.00 12/15/2021100 shares $0.00 No ChangeN/A0 $0.00 11/30/2021100 shares $0.16 No ChangeN/A0.1 $0.00 11/15/2021100 shares $0.13 No ChangeN/A0 $0.00 10/29/2021100 shares $0.06 -97.8%N/A0 $0.00 10/15/20214,600 shares $1.38 No ChangeN/A1.5 $0.00 9/30/20214,600 shares $46.00 -16.4%N/A1.1 $0.01 9/15/20215,500 shares $192.50 -14.1%N/A0.2 $0.04 8/31/20216,400 shares $192.00 +2,033.3%N/A0.2 $0.03 8/13/2021300 shares $12.75 +200.0%N/A0 $0.04 7/30/2021100 shares $2.45 -99.0%N/A0 $0.02 7/15/20219,500 shares $313.50 +9,400.0%N/A0.4 $0.03 6/30/2021100 shares $6.80 No ChangeN/A0 $0.07 6/15/2021100 shares $4.65 -66.7%N/A0 $0.05 5/28/2021300 shares $18.00 +50.0%N/A0 $0.06 5/14/2021200 shares $13.00 -71.4%N/A0 $0.07 4/30/2021700 shares $61.25 +600.0%N/A0.1 $0.09 4/15/2021100 shares $8.50 -90.9%N/A0 $0.09 3/31/20211,100 shares $88.00 -8.3%N/A0 $0.08 3/15/20211,200 shares $146.40 -90.2%N/A0 $0.12 2/26/202112,300 shares $1,474.77 +119.6%N/A0.2 $0.12 2/12/20215,600 shares $722.40 +5,500.0%N/A0 $0.13 1/29/2021100 shares $28.00 -99.0%N/A0 $0.28 1/15/202110,500 shares $840.00 +10,400.0%N/A0.3 $0.08This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. 12/31/202014,000 shares $280.00 +33.3%N/A0.2 $0.02 12/15/202010,500 shares $252.00 +10,400.0%N/A0.3 $0.02 11/30/2020100 shares $0.88 No ChangeN/A0 $0.01 11/15/2020100 shares $0.80 No ChangeN/A0 $0.01 10/30/2020100 shares $0.61 No ChangeN/A0 $0.01 10/15/2020100 shares $0.00 -97.2%N/A0 $0.00 ROSGQ Short Interest - Frequently Asked Questions What is Rosetta Genomics' current short interest? Short interest is the volume of Rosetta Genomics shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 100 shares of ROSGQ short. Learn More on Rosetta Genomics' current short interest. How does Rosetta Genomics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Rosetta Genomics: eFFECTOR Therapeutics, Inc. (16.84%), LAVA Therapeutics (0.02%), Mainz Biomed (9.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Rosetta Genomics stock? Short selling ROSGQ is an investing strategy that aims to generate trading profit from Rosetta Genomics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rosetta Genomics? A short squeeze for Rosetta Genomics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ROSGQ, which in turn drives the price of the stock up even further. How often is Rosetta Genomics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ROSGQ, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Abliva AB (publ) Short Interest Data Affymax Short Interest Data Anthera Pharmaceuticals Short Interest Data eFFECTOR Therapeutics Short Interest Data EPIRUS Biopharmaceuticals Short Interest Data GelStat Short Interest Data GlobeImmune Short Interest Data Interpharm Short Interest Data LAVA Therapeutics Short Interest Data Mainz Biomed Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ROSGQ) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rosetta Genomics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rosetta Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
